ID

41203

Beschreibung

A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GAGE); ODM derived from: https://clinicaltrials.gov/show/NCT01414205

Link

https://clinicaltrials.gov/show/NCT01414205

Stichworte

Versionen (1)
  1. 12.07.20 12.07.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

12. Juli 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Lymphocytic Leukemia, Chronic NCT01414205

Englisch

Eligibility Lymphocytic Leukemia, Chronic NCT01414205

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
cluster of differentiation antigen 20 (cd20)-positive b-cell chronic lymphocytic leukemia [per international workshop on chronic lymphocytic leukemia (iwcll) guidelines]
Beschreibung

B-cell chronic lymphocytic leukemia CD20 positive

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0475774
UMLS CUI [1,2]
C3888518
rai stage iii/iv or binet stage c disease, or rai stage i/ii or binet stage b disease that requires treatment according to iwcll guidelines
Beschreibung

Disease Rai Staging System | Disease Binet Staging System | Treatment required

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1514715
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C1511118
UMLS CUI [3]
C0332121
no previous treatment for cll chemotherapy, radiotherapy or immunotherapy; no previous rituximab treatment for autoimmune hemolytic anemia (aiha) or idiopathic thrombocytopenic purpura (itp); prior use of steroids for aiha or itp is allowed
Beschreibung

Chemotherapy Absent Chronic Lymphocytic Leukemia | Therapeutic radiology procedure Absent Chronic Lymphocytic Leukemia | Immunotherapy Absent Chronic Lymphocytic Leukemia | Rituximab Absent | Autoimmune hemolytic anemia | Acute idiopathic thrombocytopenic purpura

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0023434
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0023434
UMLS CUI [3,1]
C0021083
UMLS CUI [3,2]
C0332197
UMLS CUI [3,3]
C0023434
UMLS CUI [4,1]
C0393022
UMLS CUI [4,2]
C0332197
UMLS CUI [5]
C0002880
UMLS CUI [6]
C0272292
eastern cooperative oncology group performance status of 0, 1 or 2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
transformation of cll to aggressive b-cell malignancy
Beschreibung

Transformation Chronic Lymphocytic Leukemia | Transformation Aggressive cancer B-cell

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0040682
UMLS CUI [1,2]
C0023434
UMLS CUI [2,1]
C0040682
UMLS CUI [2,2]
C2945759
UMLS CUI [2,3]
C0004561
history of severe allergic or anaphylactic reactions to monoclonal antibody therapy
Beschreibung

Allergic Reaction Severe Monoclonal Antibody Therapy | Anaphylaxis Severe Monoclonal Antibody Therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0279694
UMLS CUI [2,1]
C0002792
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0279694
evidence of severe, uncontrolled concomitant disease
Beschreibung

Comorbidity Severe Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0205318
known active infection or any major episode of infection requiring treatment with iv antibiotics or hospitalization within 4 weeks before the start of cycle 1
Beschreibung

Communicable Disease | Episode Major Communicable Disease | Requirement Antibiotics Intravenous | Hospitalization Required

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2,1]
C0332189
UMLS CUI [2,2]
C0205164
UMLS CUI [2,3]
C0009450
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0003232
UMLS CUI [3,3]
C1522726
UMLS CUI [4]
C1708385
seropositive for human immunodeficiency virus (hiv)
Beschreibung

HIV Seropositivity

Datentyp

boolean

Alias
UMLS CUI [1]
C0019699
positive for chronic hepatitis b infection (defined as positive hbsag serology)
Beschreibung

Chronic Hepatitis B Positive | Serology positive Hepatitis B Surface Antigens

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0524909
UMLS CUI [1,2]
C1514241
UMLS CUI [2,1]
C0242089
UMLS CUI [2,2]
C0019168
positive for hepatitis c (hepatitis c virus [hcv] antibody serology testing)
Beschreibung

Hepatitis C positive | Hepatitis C Antibodies Serologic tests

Datentyp

boolean

Alias
UMLS CUI [1]
C1112419
UMLS CUI [2,1]
C0166049
UMLS CUI [2,2]
C0036743
pregnant or lactating women
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
concurrent (or within 7 days prior to fist dose of study treatment) systemic corticosteroid use, except for low-dose corticosteroid therapy used to treat illness other than lymphoma
Beschreibung

Systemic Corticosteroid Therapy | Exception Steroid therapy Low dose

Datentyp

boolean

Alias
UMLS CUI [1]
C4053960
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0149783
UMLS CUI [2,3]
C0445550
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Lymphocytic Leukemia, Chronic NCT01414205

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
B-cell chronic lymphocytic leukemia CD20 positive
Item
cluster of differentiation antigen 20 (cd20)-positive b-cell chronic lymphocytic leukemia [per international workshop on chronic lymphocytic leukemia (iwcll) guidelines]
boolean
C0475774 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
Disease Rai Staging System | Disease Binet Staging System | Treatment required
Item
rai stage iii/iv or binet stage c disease, or rai stage i/ii or binet stage b disease that requires treatment according to iwcll guidelines
boolean
C0012634 (UMLS CUI [1,1])
C1514715 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C1511118 (UMLS CUI [2,2])
C0332121 (UMLS CUI [3])
Chemotherapy Absent Chronic Lymphocytic Leukemia | Therapeutic radiology procedure Absent Chronic Lymphocytic Leukemia | Immunotherapy Absent Chronic Lymphocytic Leukemia | Rituximab Absent | Autoimmune hemolytic anemia | Acute idiopathic thrombocytopenic purpura
Item
no previous treatment for cll chemotherapy, radiotherapy or immunotherapy; no previous rituximab treatment for autoimmune hemolytic anemia (aiha) or idiopathic thrombocytopenic purpura (itp); prior use of steroids for aiha or itp is allowed
boolean
C0392920 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0023434 (UMLS CUI [2,3])
C0021083 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0023434 (UMLS CUI [3,3])
C0393022 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0002880 (UMLS CUI [5])
C0272292 (UMLS CUI [6])
ECOG performance status
Item
eastern cooperative oncology group performance status of 0, 1 or 2
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Transformation Chronic Lymphocytic Leukemia | Transformation Aggressive cancer B-cell
Item
transformation of cll to aggressive b-cell malignancy
boolean
C0040682 (UMLS CUI [1,1])
C0023434 (UMLS CUI [1,2])
C0040682 (UMLS CUI [2,1])
C2945759 (UMLS CUI [2,2])
C0004561 (UMLS CUI [2,3])
Allergic Reaction Severe Monoclonal Antibody Therapy | Anaphylaxis Severe Monoclonal Antibody Therapy
Item
history of severe allergic or anaphylactic reactions to monoclonal antibody therapy
boolean
C1527304 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0279694 (UMLS CUI [1,3])
C0002792 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0279694 (UMLS CUI [2,3])
Comorbidity Severe Uncontrolled
Item
evidence of severe, uncontrolled concomitant disease
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
Communicable Disease | Episode Major Communicable Disease | Requirement Antibiotics Intravenous | Hospitalization Required
Item
known active infection or any major episode of infection requiring treatment with iv antibiotics or hospitalization within 4 weeks before the start of cycle 1
boolean
C0009450 (UMLS CUI [1])
C0332189 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C0009450 (UMLS CUI [2,3])
C1514873 (UMLS CUI [3,1])
C0003232 (UMLS CUI [3,2])
C1522726 (UMLS CUI [3,3])
C1708385 (UMLS CUI [4])
HIV Seropositivity
Item
seropositive for human immunodeficiency virus (hiv)
boolean
C0019699 (UMLS CUI [1])
Chronic Hepatitis B Positive | Serology positive Hepatitis B Surface Antigens
Item
positive for chronic hepatitis b infection (defined as positive hbsag serology)
boolean
C0524909 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0242089 (UMLS CUI [2,1])
C0019168 (UMLS CUI [2,2])
Hepatitis C positive | Hepatitis C Antibodies Serologic tests
Item
positive for hepatitis c (hepatitis c virus [hcv] antibody serology testing)
boolean
C1112419 (UMLS CUI [1])
C0166049 (UMLS CUI [2,1])
C0036743 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Systemic Corticosteroid Therapy | Exception Steroid therapy Low dose
Item
concurrent (or within 7 days prior to fist dose of study treatment) systemic corticosteroid use, except for low-dose corticosteroid therapy used to treat illness other than lymphoma
boolean
C4053960 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0149783 (UMLS CUI [2,2])
C0445550 (UMLS CUI [2,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video